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Image findings of cranial nerve pathology
on [18F]-2- deoxy-D-glucose (FDG) positron
emission tomography with computerized
tomography (PET/CT): a pictorial essay
Osama A. Raslan1*, Razi Muzaffar1, Vilaas Shetty2 and Medhat M. Osman1
Abstract
This article aims to increase awareness about the utility of 18F -FDG-PET/CT in the evaluation of cranial nerve (CN)
pathology. We discuss the clinical implication of detecting perineural tumor spread, emphasize the primary and
secondary 18F -FDG-PET/CT findings of CN pathology, and illustrate the individual 18F -FDG-PET/CT CN anatomy and
pathology of 11 of the 12 CNs.
Background
Conventional CT and MRI have been the imaging mo-
dalities of choice for evaluation of cranial nerve (CN)
pathology. However, CN pathology can also be detected
on [18 F]-2- deoxy-D-glucose (FDG) positron emission
tomography with computerized tomography (PET/CT)
imaging [1–3]. As FDG PET/CT is increasingly being
used for oncologic imaging and more specifically for
evaluation of head and neck (HN) cancer [4], PET/CT
interpreters need to familiarize themselves with the
image findings of CN involvement, which will greatly
impact the staging and management of these patients.
Tumor related PET/CT findings include the perineural
spread of HN tumors which represents a rare contiguous
metastatic extension of tumor along a cranial nerve that
portends to poor prognosis, even if the patient is asymp-
tomatic [2, 5]. If present, treatment can be changed to
include neck dissection, a larger radiation field, or add-
ing adjuvant therapy [6–8]. Facial nerve involvement
(CN VII) in parotid tumors may preclude facial nerve–
sparing surgery or require additional treatment modality
[9]. Patients with skin cancer and perineural invasion
will require adjuvant radiation therapy even when clear
margins are achieved with Mohs surgery [10, 11]. Also
the degree of FDG uptake by the tumor as measured by
the SUV max is an important prognostic marker for
locally advanced nasopharyngeal cancer. High FDG uptake
reflects more aggressive tumors that may require more
aggressive treatment and carries a worse prognosis, as
compared to the less aggressive low FDG tumors [12].
Non-tumor related benign and malignant cranial nerve
pathology can also be incidentally detected during PET/CT
oncologic imaging including schwannomas [13], optic
nerve glioma [14], meningioma [15], and melanoma [15].
Gallium 68 (68Ga) 1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraaceticacid (DOTA)–octreotate (DOTATATE, GaTate),
has been shown to be more sensitive than FDG-PET/CT in
detection of low grade somatostatin receptor positive
tumors namely meningioma, esthesioneuroblastoma and
schwannoma [16].
The purpose of this article is to describe the primary
and secondary FDG-PET/CT findings of CN pathology
and to provide a comprehensive illustration of the PET/
CT cross-sectional anatomy and pathology of almost
each individual CN, thus raising awareness and familiar-
ity about incidental CN lesions seen on PET/CT, which
will directly reflect on patient staging and management.
Primary and secondary PET/CT findings of CN
pathology
The primary sign of CN pathology includes linear thick-
ening or linear increased/decreased FDG activity along
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the expected course of the CN (Fig. 1). For this purpose,
all three planes (axial, coronal and sagittal) and maximum
intensity projection (MIP) images must be evaluated and
correlations with all other available imaging modalities, e.g.
(CT or MRI) which will often confirm the abnormality.
The secondary signs of CN pathology include widen-
ing or destruction at the corresponding skull base for-
amen, asymmetric atrophy or abnormal activity in the
muscles supplied by the CN, or increased FDG activity
related to synergistic/antagonistic muscle overcompensa-
tion to maintain function (Table 1).
Case presentation
Olfactory nerve (CN I)
Direct visualization of the CN I lesion is beyond the
resolution of PET/CT, however CN I involvement
Fig. 1 A 50-year-old female who is status post excision of left nasolabial melanoma,presenting with left perioral numbness. Sagittal
unfused (a) and fused (b) FDG PET/CT shows alongitudinal hypermetabolic mass extending retrogradely along the expected course of
theinfraorbital branch Of V2 in the orbital floor, with intracranial extension (arrow). Sagittal (c), axial (d) curved Multiplanar reformatted
images (MPR) of fat suppressed post contrast T1 WI MRI confirming retrograde perineural metastatic melanoma, along the infraorbital
branch of V2 (red arrow), through the foramen rotundum (asterix), into the cavernous sinus (blue arrow), to the cisternal portion of the
left trigeminal nerve (green arrow)
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should be suspected in lesions involving the superior
sinonasal and anterior cranial fossa region. The dif-
ferential considerations include olfactory neuroblast-
oma (Esthesioneuroblastoma), sinonasal carcinoma
and melanoma (Fig. 2).
Optic nerve (CN II)
The main differential considerations for CN II lesion in-
clude optic pathway glioma (OPG), optic nerve sheath
meningioma, idiopathic orbital inflammatory pseudotu-
mor, and optic neuritis. FDG activity in Optic nerve glioma
Table 1 Clinical, primary and secondary findings of CN pathology
Symptoms/signs that
trigger search pattern for
CN pathology
Which CN to suspect? What to look for and where to look for it on PET/CT?
Primary Sign Secondary Signs
Abnormality along
course of CN
Abnormal skull
base foramen/
bone
Muscle atrophy Over compensation
Anosmia CN I (Olfactory) Roof of nose and
anterior cranial
fossa
Cribriform plate of
ethmoid
– –
Visual loss CN II (Optic) Orbit, suprasellar
cistern
Optic canal – –
Diplopia CN III (Oculomotor) Cavernous sinus Superior orbital
fissure (SOF)
Extraocular
muscles (except
superior oblique
and lateral rectus
muscles)
–
Vertical diplopia CN IV (Trochlear) Cavernous sinus SOF Superior oblique –
Trigeminal Neuralgia CN V (Trigeminal,
main trunk)
Pons, prepontine
cistern, Meckel's
cave.
– – –
Paresthesia over forehead
and eye
CN V1 (Ophthalmic
division)
Cavernous sinus SOF – –
Paresthesia over cheek CN V2 (Maxillary
division)
Cavernous sinus,
cheek
Foramen
rotundum,
pterygopalatine
fossa and
infraorbital canal
/foramen
– –
Paresthesia over chin,
trismus
CN V3 (Mandibular
division)
Masticator space Foramen ovale,
mandibular canal
and mental
foramen
– –
Lateral gaze diplopia CN VI( Abducens) Cavernous sinus,
clivus
SOF Lateral rectus Ipsilateral Medial rectus
Facial palsy CN VII (Facial) Cerebellopontine
angle , parotid
space
Petrous bone,
internal auditory
canal (IAC), and
stylomastoid
foramen
– –
Hearing loss/ imbalance CN VIII
(Vestibulocochlear)
Cerebellopontine
angle
Petrous bone and
IAC
– –
Hoarseness CN X (Vagus nerve,
recurrent laryngeal
branch)
Carotid space, tracheoesophageal
grooves, around aortic
root
Jugular foramen (JF) Ipsilateral vocal cord Contralateral vocal
cord
Shoulder drooping CN XI (Spinal
accessory)
Carotid space JF, foramen
magnum
Sternomastoid
and trapezius
muscles
–
Dysarthria and dysphagia CN XII (Hypoglossal
nerve)
occipital condyles
, Carotid space,
base of tongue
JF, Hypoglossal
canal
Ipsilateral
hemitongue
Contralateral hemitounge
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is variable depending on its histological grade [17, 18].
Some authors suggested the use of FDG-PET/CT in moni-
toring malignant transformation of OPG in children with
neurofibromatosis type 1 syndrome [17, 19]. Optic men-
ingioma is a benign tumor that typically demonstrate min-
imal to no FDG uptake on PET [15] and can be associated
with bony sclerosis/destruction as in our case (Fig. 3). Or-
bital pseudotumor could be both hyper or isometabolic on
FDG PET [18]. Xie et al. described a 56-year-old female
with elevated FDG activity in several cranial and peripheral
nerves suggestive of multiple neuritis, with patient“s symp-
toms improving following treatment [3].
Oculomotor, trochlear and abducens nerves
(CN III, IV, VI)
Direct visualization of CNs III, IV and VI is usually be-
yond the resolution of PET/CT, however large brain
stem or cavernous sinus lesions along the course of
these nerves may indicate cranial nerve involvement by
these lesions. Also, extraocular muscle atrophy or asym-
metric decreased uptake could represent denervation in-
jury, which should prompt a search for a lesion along
the course of the innervating CN. In an attempt to com-
pensate for the paralyzed muscle, the non affected
extraocular muscles may show increased FDG activity,
further confirming the CN involvement (Fig. 4c–e).
Fig. 3 A 74-year-old female complaining of double vision. Axial post
contrast T1 WI MRI (a, b), The right optic nerve demonstrates the
normal anatomy, showing the four segments of the optic nerve, the
retinal (red arrow), orbital (arrow head), canalicular (green arrow) and
cisternal parts (white arrow). The optic chiasm is also seen (orange
arrow). On the left side, ahomogenously enhancing extra axial mass is
seen centered on the eroded left greater wing of thesphenoid bone
encasing the left optic nerve. Axial CT soft tissue (c) and bone
windows (d), axialPET (e), and fused PET/CT (f) images, showing a
hypometabolic soft tissue mass causinghyperostosis and erosion of the
left greater wing of the sphenoid and extending into the orbitalcavity
along the optic nerve. Diagnosis sphenoid wing meningioma with
intra orbital extension,encasing the optic nerve
Fig. 2 a Sagittal steady state free precession (SSFP) MRI image of the
brain showing the olfactory nerve anatomy: The fibers in the superior
nasal mucosa (yellow fibers), ascend through the fenestrated cribriform
plate of the ethmoid bone (green dashed line) to reach the
anteriorcranial fossa and continue as the olfactory bulb (red arrow) and
tract (green arrow) coursing atthe inferior surface of the ipsilateral frontal
lobe. b–e A 38-year-old male presented with a 6month history of
anosmia and episodic epiphoresis, nasal stuffiness. Coronal fused (a)
andunfused (b) PET/CT images demonstrate a large aggressive
hypermetabolic mass centered on thesuperior aspect of the nasal cavity,
extending superiorly into the right anterior cranial fossa andcribriform
plate of ethmoid bone, involving the expected location of the right
olfactorynerve/bulb/track (arrow). Our differential diagnosis was olfactory
neuroblastoma (Esthesioneuroblastoma), or sinonasal carcinoma/
melanoma. Coronal contrast enhanced CT (c) demonstrate the
enhancing mass extending into the anterior cranial fossa at the expected
locationof CNI. Coronal short tau inversion recovery (STIR) (e) images
confirm the intracranial extension (arrow) with involvement
of the right olfactory nerve/bulb (red arrow). Note the normal left
olfactory track (green arrowhead). Surgical pathology showed an
olfactory neuroblastom
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Trigeminal nerve, maxillary and mandibular
divisions (CNV, V2 & V3)
FDG-PET/CT can detect perineural tumor spread along
the trigeminal nerve and its main divisions; most
commonly arising from head and neck squamous cell
carcinoma, adenoid cystic carcinoma, mucoepider-
moid carcinoma, skin cancer and melanoma as well as
[2] lymphoma [1] and neurolymphomatosis [20] (Fig. 5).
Facial/ vestibulocochlear nerve complex
(CNVII and VIII)
The most common cerebellopontine angle lesions are
vestibular schwannoma and meningioma. Vestibular
schwannoma is typically described as a hypometabolic
lesion [21], however in our experience they were
Fig. 4 Axial Fast imaging employing steady-state acquisition
(FIESTA) MRI image (a) showing the CNIII (yellow arrows) entering
the cavernous sinus (asterix). From here, CNIII courses anteriorly in
the dura of the cavernous sinus to enter the orbit through the
superior orbital fissure (SOF), supplying the extra ocular muscles
except the superior oblique and lateral rectus muscles. Axial FIESTA
MRI image (b) shows the normal abducens nerves (red arrow)
entering Dorello’s canal (green arrow). From here, CN VI courses
anteriorly through the cavernous sinus to enter the orbit through
the SOF, supplying the lateral rectus muscle. The white arrows show
the general direction of travel of CN III and VI (a, b). A 73-year-old
male presenting complaining of double vision. Axial fused PET/CT
(c), PET (d), and coronal PET (e) images showing a large peripherally
ossified hypometabolic expansile mass centered in the left petrous
apex extending to the cerebellopontine angle and middle cranial
fossa (long green arrow). Note the lower activity in the left lateral
rectus muscle (green short arrow) compared to the right one (red
arrow) and the overcompensating hypermetabolic left medial rectus
muscle, indicative of left abducens nerve paresis which was confirmed
clinically. f Zoomed in Axial FIESTA MRI imaging shows the
normal right abducens nerve (red arrow) entering Dorello’s
canal (green arrow). On the left side, the mass is seen involving
the expected location of the left CN VI
Fig. 5 A 41-year-old male with nasopharyngeal squamous cell
carcinoma. Axial CT (a), and PET (b) images show an iso/hyperdense
hypermetbolic mass extending into the enlarged left pterygopalatine
fossa (red arrow) and foramen ovale (red arrowhead), confirming
perineural tumor spread along the maxillary (V2) and mandibular (V3)
divisions of the trigeminal (CNV) nerve. Note the normal appearance
of the right pterygopalatine fossa (green arrow) and foramen ovale
(green arrowhead). Axial contrast-enhanced fat suppressed T1 SI MR
(c, d) of the neck confirm extension of the enhancing soft tissue mass
from the left cavernous sinus/Meckel’s cave region in to the left
pterygopalatine fossa (red arrow). Coronal fused PET/CT (e) and
contrast-enhanced fat suppressed T1 SI MR (f) confirming perineural
extension of the tumor along V3, infiltrating the left cavernous sinus/
Meckel’s cave region (arrow) and widening the ipsilateral foramen
ovale (arrowhead)
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hypermetabolic (Fig. 6c-f), which may be related to the
large size of the lesions. Vestibular schwannoma is dif-
ferentiated from meningioma by extension into the in-
ternal auditory canal (Fig. 6f ). The less common facial
nerve schwannoma is diagnosed when the lesion extends
along the labyrinthine segment of CNVII (Fig. 6g, h).
Perineural spread form parotid gland lesions should be
suspected with abnormal activity extending superiorly
along the stylomastoid foramen or within the temporal
bone [2, 22, 23]. Rare CN melanoma metastasis along
CNs VII and VIII has also been described [24].
Vagus and spinal accessory nerves (CNs X and XI)
The most common jugular foramen (JF) lesions that my
involve CN X and XI are glomus juglare, schwannoma,
meningioma and skull base metastasis. Looking at the
bone margins of the JF on the bone window of PET/CT
may help differentiate glomus tumors which tend to
have a permeative destructive margins from schwan-
noma which tend to cause smooth expansion of the JF
(Fig. 7e) and meningioma, which may have permeative
sclerotic margins [25]. If the recurrent laryngeal branch
of CNX is involved, it will be seen as a hypometabolic
ipsilateral paralyzed vocal cord with a hypermetabolic
overcompensating contralateral vocal cord (Fig. 7c, d).
Ipsilateral shoulder dropping on MIP images (Fig. 7g),
with atrophy of the trapezius and sternomastoid muscles
on the axial images (Fig. 7c, d), signifies CNXI involve-
ment, which could be secondary to CNXI sacrifice dur-
ing neck dissection.
Hypoglossal nerve (CN XII)
Injury of CNXII could occur by the aforementioned JF le-
sions [25]. Further distally it could be secondary to hypo-
glossal foramen lesions (CNXII Schwannoma [25, 26]),
clival tumor (chordoma, chondrosarcoma and plasmacy-
toma) [25], or rarely could be secondary to retrospective
perineural tumor spread from tongue base tumor or radi-
ation injury. An atrophic sagging fatty infiltrated ipsilateral
tongue will be seen with hypometabolism on PET/CT
(Fig. 8 b, d, e) [25].
Conclusion
Cranial nerve pathology can be detected on FDG PET/CT.
With the increased reliance on PET/CT in patient staging
and follow-up, PET/CT interpreters should familiarize
themselves with these findings as it may change patient
staging and management.
Consent
“This retrospective study was approved by the Saint
Louis University IRB board”.
Fig. 6 Axial (a) and coronal (b) low resolution CT part of PET/CT.
a On the axial view the internal auditory canal parts of CNVII and VIII
(red arrow), as well as the labyrinthine (bluearrow) and tympanic
parts (green arrow) of CN VII can be visualized. b On the coronal
view,the styloid process (red arrow) can be used as a landmark to
visualize the stylomastoid foramen,containing the stylomastoid part
of CN VII (arrow heads). c–f A 62 year-old-female with rightsided
hearing loss. Axial fused/non fused FDG PET/CT (c, d) and coronal
Maximum Intensity projection (MIP) (e) images showing an intensely
hypermetabolic right cerebellopontine angle lesion (CPA) lesion.
Given patient history of hearing loss, this was consistent with
vestibular schwannoma, rather than a meningioma. Axial contrast
enhanced T1 WI MRI (f) showing the classic heterogeneously
enhancing “ice cream cone” mass extending into the right internal
auditory canal (IAC) (arrow), consistent with vestibular schwannoma,
which was confirmed pathologically. g, h A 71-yearold female
patient with history of worsening right sided hearing loss,
unsteadiness, and neck pain. Axial unfused PET/CT images (g) and
contrast enhanced T1 WI MRI (h) show a right CPA enhancing lesion
with mild focal FDG activity (SUVmax 3.0) (green arrow), extending
along the IAC, labyrinthine and tympanic segments of CN7 (red arrow)
confirming that this is a facial nerve schwannoma rather than the
more common vestibular nerve schwannoma
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Fig. 7 A 32 year-old-female presenting with a hoarse voice. Axial fused (a) and unfused (b) PET/CT images of the skull base showing a
hypometabolic soft tissue mass centered on the left jugular foramen with smooth osseous expansion suggestive of schwannoma of cranial nerve
IX, X or XI which all exit the skull base through the jugular foramen. Axial fused (c) and unfused (d) PET/CT images at the level of the glottis
show no 18F-FDG uptake in the left vocal cord (blue arrow) with compensatory increased activity in the right vocal cord, consistent with
laryngoscopy proven left vocal cord paralysis due to tumor involvement of left CN X and its recurrent laryngeal branch. Asymmetric atrophy of
the left sternomastoid and trapezius muscles is consistent with chronic denervation due to tumor involvement of the left cranial nerve XI (spinal
accessory nerve) (red arrows). Axial CT scan of the skull base with bone window settings (e) and axial post-contrast fat-suppressed T1 MRI (f) at
the same level show the enhancing left cranial nerve IX/X/XI mass pathologically proven to be a schwannoma. g Coronal MIP image of a 50-
year-old male with HIV presenting with worsening right facial weakness and pathologically proven squamous cell carcinoma of the neck, with
perineural tumor invasion along the jugular foramen (not shown), showing right shoulder drooping compared to the left one (red line),
secondary to atrophy of the right trapezius and sternomastoid muscles, confirmingCN XI involvement. Also note the bulky hypermetabolic
cervical adenopathy (arrow) in the rightneck involving lymph node levels 1 through 4 consistent with metastatic lymph nodes
Fig. 8 A 41 year-old-male patient diagnosed with left sided nasopharyngeal carcinoma and intracranial involvement. Axial CT of the neck (a)
at the time of diagnosis (5/2005) showing normal posterior contour of the tongue (red line). The patient received radiotherapy and
chemotherapy ending in 2006. Follow-up axial fused PET/CT images of the neck region (b) on (8/2013) shows interval atrophy of the left
hemi-tongue, with abnormal posterior contour (green line). Post contrast coronal T1 WI before treatment (c), coronal fused PET/CT and
coronal contrast enhanced MRI T1W images after treatment (d, e) confirming the left hemi tongue atrophy (arrow). Clinically, the patients
tongue deviates to the left. The constellation of findings is consistent with post radiation hypoglossal neuropathy
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